Clinical trial
An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium)…
NCT00261599 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00261599 |
|---|---|
| Title | An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Colonoscopy |
| Official title | A Phase 3, Randomized, Double-Blind, Dose-Controlled Study to Assess the Efficacy and Safety of AQUAVAN® (Fospropofol Disodium) Injection for Minimal to Moderate Sedation in Patients Undergoing Colonoscopy |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Conscious Sedation |
| Intervention type | Drug |
| Interventions | AQUAVAN® (fospropofol disodium) Injection, Midazolam HCI |
| Enrollment | 300 |
| Start date | Mar 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Dec 5, 2005 |
| Last update posted | Nov 7, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: